65,437 trials
Cushing's Syndrome
Primary: Improvement in Diabetes and/or Glucose Intolerance. — 15 participants
Lateral Elbow Pain
Primary: Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire — 18; 13 units on a scale
Congestive Heart Failure
Primary: Long-term Effectiveness of the COROX Over-the-wire (OTW) Steroid in Providing Biventricular Pacing — 1.3 Threshold Voltage
Asthma
Primary: Change in Forced Expiratory Volume in 1 Second (FEV1) — -24.66; -8.44; -9.15; -16.17 Percentage drop in FEV1 — p=<0.0001
Peripheral Vascular Diseases
Primary: Efficacy: Primary Patency at Three Years — 24.2; 25.9 percentage of subjects
Coronary Artery Disease
Primary: Target Lesion Failure (TLF) — 4.7 percentage of participants
Dysmenorrhea
Primary: Mean Change in Average Severity for Abdominal/Pelvic Pain — -0.45; -0.19 units on a scale
Cerebral Vasospasm After Subarachnoid Hemorrhage
Primary: Hemodynamic Parameters (Change From Baseline Systolic Blood Pressure (Pre-infusion) Over Time Until 135 Minutes Post-infusion) — -8; -3.4 mmHg
Nocturia
Primary: Duration of Action Defined as the Time With Urine Osmolality Above 200 mOsm/kg - Period 1 — 0.00; 0.09; 2.00; 3.45 hours — p=0.211
Metastatic Breast Cancer
Primary: Progression-Free Survival (PFS) at 6 Months (6-month PFS Rate): Proportion of Participants Progression Free at 6 Months — 28.6; 42.7 Percentage of Participants — p=0.03
Total Knee Arthroplasty · Osteoarthritis
Primary: Postoperative Range of Motion (ROM) — 102.3; 106.8; 117.6; 118.2 degrees
Respiratory Tract Diseases
Primary: Number of Participants With Wild Type-4 Febrile Adenovirus (ADV) Acute Respiratory Disease (ARD) -- ITT Cohort — 1; 48 participants
Idiopathic Pulmonary Fibrosis
Primary: Time to Occurrence of Disease Worsening or Death up to End of Study. — 10; 18; 22; 40 participants with event — p=0.2110
Congenital Heart Disease
Primary: Number of Patients With a Closed Patent Ductus Arteriosus (Defect) Determinated by Echocardiography ( Time Frame: One Year After Treatment) — 19; 23; 28; 29 Participants…
Colorectal Cancer
Primary: Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage. — 4 Participants